Abstract:Introduction: In preclinical cardiovascular safety pharmacology studies, statistical analysis of the rate corrected QT interval (QTc) is the focus for predicting QTc interval changes in the clinic. Modeling of a concentration/QTc relationship, common clinically, is limited due to minimal pharmacokinetic (PK) data in nonclinical testing. It is possible, however, to relate the average drug plasma concentration from sparse PK samples over specific times to the mean corrected QTc. We hypothesize that averaging drug plasma concentration and the QTc-rate relationship over time provides a simple, accurate concentration-QTc relationship bridging statistical and concentration/QTc modeling. Methods: Cardiovascular telemetry studies were conducted in non-human primates (NHP; n = 48) and canines (n = 8). Pharmacokinetic samples were collected on separate study days in both species. Average plasma concentrations for specific intervals (CAverage0-X) were calculated for moxifloxacin in canines and NHP using times corresponding to super-intervals for the QTc data statistical analysis. The QTc effect was calculated for each super-interval using a linear regression correction incorporating QT and HR data from the whole super-interval. The concentration QTc effects were then modeled. Results: In NHP, a 10.9 ± 0.06 ms (mean ± 95% CI) change in QTc was detected at approximately 1.5× the moxifloxacin plasma concentration that causes a 10 ms QTc change in humans, based on a 0-24 h super-interval. When simulating a drug without QT effects, mock, no effect on QTc was detected at up to 3× the clinical concentration. Similarly, in canines, a 16.6 ± 0.1 ms change was detected at 1.7× critical clinical moxifloxacin concentration, and a 0.04 ± 0.1 ms change was seen for mock. Conclusions: While simultaneous PK and QTc data points are preferred, practical constraints and the need for QTc averaging did not prevent concentration-QTc analyses. Utilizing a 0-24 h super-interval method illustrates a simple and effective method to address cardiovascular questions when preclinical drug exposures exceed clinical concentrations.

A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion

Application of Ivive and Pbpk Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies

Absorption Barriers in the Rat Intestinal Mucosa: 2. Application of Physiologically Based Mathematical Models to Quantify Mechanisms of Drug Permeation and Metabolism

Three-Bottle Exponential Decay Infusion: A Novel Intravenous Infusion Strategy for Drugs Which Conform to Three-Compartment Model with Observations on Propofol Kinetics

The Simulation of the Influence of Two-Compartment Model Parameters on the Plasma Drug Concentration and Drug Effect

Reinforcement Learning Based Model Selection and Parameter Estimation for Pharmacokinetic Analysis in Drug Selection.

One-compartment Model with Michaelis-Menten Elimination Kinetics and Therapeutic Window: an Analytical Approach.

Steady-State Drug Exposure of Repeated IV Bolus Administration for a One Compartment Pharmacokinetic Model with Sigmoidal Hill Elimination

Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models

In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy

Nonlinear least-squares regression analysis by a simplex method using differential equations containing Michaelis-Menten type rate constants

A fuzzy neartude based approach to simulate the two-compartment pharmacokinetic model

Establishment and Assessment of a Novel in Vitro Bio-Pk/pd System in Predicting the in Vivo Pharmacokinetics and Pharmacodynamics of Cyclophosphamide

A simple accurate method for concentration-QTc analysis in preclinical animal models

Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method

A simulation study of sampling time point designing for therapeutic drug monitoring based on a population pharmacokinetic model

Fractional Calculus in Pharmacokinetics

Analysis of multidrug effects by parameter method

A Novel Parameter Estimation Method for Drug Diffusion, Distribution and Clearance in the Rat Brain Extracellular Space

Pharmacokinetic model for extravascular administration based on uncertain differential equation

Comparison of various estimation methods for the parameters of Michaelis-Menten equation based on in vitro elimination kinetic simulation data